In fact, in the absence of IL-1RT1 signaling gastric pathology develops more rapidly and extensively in both the antrum and gastric cardia suggesting that IL-1RT1 signaling may minimize tumor burden by antagonizing IL-11/STAT3 mediated pathology. The gene discussed is IL11; the disease is neoplasm.